CERAMICS Trial Shows 71 Percent Survival with Early MCS and Escalation in AMI Cardiogenic Shock
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok